lanreotide
Showing 1 - 20 of 20
Paraganglioma, Pheochromocytoma Trial in New York, Cleveland (Lanreotide)
Recruiting
- Paraganglioma
- Pheochromocytoma
- Lanreotide
-
New York, New York
- +1 more
Oct 5, 2022
Neuroendocrine Tumors, Gastrointestinal Tumors, Carcinoid Tumors Trial in Denver, Kansas City, Nashville (Lanreotide, Y-90
Terminated
- Neuroendocrine Tumors
- +2 more
- Lanreotide
- Y-90 microspheres
-
Denver, Colorado
- +2 more
Jul 5, 2022
Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours Trial in Worldwide (lanreotide, Placebo)
Terminated
- Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours
- lanreotide
- Placebo
-
Bruxelles, Belgium
- +23 more
Dec 21, 2022
Acromegaly Trial in Los Angeles (Pegvisomant, Octreotide LAR, Lanreotide)
Terminated
- Acromegaly
- Pegvisomant
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Dec 12, 2022
Metastatic Well Differentiated Neuroendocrine Tumor, Neuroendocrine Tumors Trial in Milano (Cabozantinib, Lanreotide)
Recruiting
- Metastatic Well Differentiated Neuroendocrine Neoplasm
- Neuroendocrine Tumors
- Cabozantinib
- Lanreotide
-
Milano, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Sep 3, 2021
Neuroendocrine Tumors,Gastroenteropancreatic Trial in Taipei (Cabozantinib, Lanreotide)
Not yet recruiting
- Neuroendocrine Tumors,Gastroenteropancreatic
- Cabozantinib
- Lanreotide
-
Taipei, TaiwanNational Taiwan University Hospital
Sep 9, 2021
Carcinoid Syndrome Trial in Worldwide (Lanreotide, Placebo)
Completed
- Carcinoid Syndrome
- Lanreotide
- Placebo
-
Los Angeles, California
- +53 more
Sep 15, 2022
Gastrointestinal Motility Disorder, Intestinal Disease Trial in New Hyde Park, New York (Lanreotide)
Completed
- Gastrointestinal Motility Disorder
- Intestinal Disease
- Lanreotide
-
New Hyde Park, New York
- +1 more
Dec 23, 2020
Acromegaly Trial in Santa Monica (lanreotide)
Terminated
- Acromegaly
- lanreotide
-
Santa Monica, CaliforniaBrain Tumor Center and Pituitary Disorders Program, John Wayne C
Sep 2, 2021
Carcinoma, Hepatocellular, Neuroendocrine Tumors Trial in Aarhus (Sorafenib, Radiofrequency ablation (RFA) or surgery,
Completed
- Carcinoma, Hepatocellular
- Neuroendocrine Tumors
- Sorafenib
- +3 more
-
Aarhus, Aarhus C, DenmarkDepartment of Hepatology and Gastroenterology
Apr 27, 2021
Small Intestinal NET, Carcinoid Heart Disease Trial (Telotristat Ethyl, Lanreotide)
Withdrawn
- Small Intestinal NET
- Carcinoid Heart Disease
- Telotristat Ethyl
- Lanreotide
- (no location specified)
Jan 30, 2020
Autosomal Dominant Polycystic Kidney Disease (ADPKD Trial in Paris (Lanreotide, saline)
Completed
- Autosomal Dominant Polycystic Kidney Disease (ADPKD
- Lanreotide
- saline
-
Paris, FranceNecker hospital
Nov 15, 2019
Neuroendocrine Tumors Trial in Seoul (Lanreotide)
Unknown status
- Neuroendocrine Tumors
- Lanreotide
-
Seoul, Korea, Republic ofYoungsuk Park
May 17, 2019
Carcinoma, Merkel Cell Trial in Grenoble (Lanreotide)
Completed
- Carcinoma, Merkel Cell
- Lanreotide
-
Grenoble, FranceGrenoble University Hospital
Oct 17, 2017
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Trial in Netherlands (Lanreotide)
Unknown status
- Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- Lanreotide
-
Groningen, Netherlands
- +3 more
May 19, 2017
Carcinoid Tumors Trial in Belgium, France (Lanreotide, Placebo (for sunitinib), Sunitinib)
Unknown status
- Carcinoid Tumors
- Lanreotide
- +2 more
-
Brussels, Belgium
- +19 more
Jan 30, 2017
Polycystic Livers (RESOLVE)
Completed
- Polycystic Liver Disease
- Lanreotide
-
Nijmegen, Gelderland, NetherlandsRadboud University Hospital
Jul 8, 2014
Acid Reflux Esophagitis, Non-acid Reflux Esophagitis Trial in Jette (Lanreotide)
Unknown status
- Acid Reflux Esophagitis
- Non-acid Reflux Esophagitis
- Lanreotide
-
Jette, BelgiumUniversity Hospital of Brussels
Jan 31, 2014
Polycystic Liver Disease, Hepatomegaly, Liver Diseases Trial in Leuven, Nijmegen (Placebo, Lanreotide)
Completed
- Polycystic Liver Disease
- +3 more
- Placebo
- Lanreotide
-
Leuven, Belgium
- +1 more
Feb 16, 2009
Polycystic Liver Disease, Hepatomegaly, Liver Diseases Trial in Leuven, Nijmegen (lanreotide)
Unknown status
- Polycystic Liver Disease
- +4 more
- lanreotide
-
Leuven, Belgium
- +1 more
Nov 12, 2008